Research is fundamental to FDA's ability to provide effective regulatory review of biological products. A wide variety of rapidly evolving technical and scientific issues concerning the safety, potency, and efficacy of new biological products requires knowledge of new developments in basic research in the relevant biological disciplines.
For this reason, FDA scientists in our Center for Biologics Evaluation and Research (CBER) conduct a variety of mission-related programs, including research into allergenics, blood, cellular and gene therapy, and vaccines, to name a few. This research broadens FDA's knowledge of fundamental biological processes and provides a robust scientific base for regulatory review.
In this Web section you will find information on some of the research programs conducted by CBER scientists and their published scientific articles.
CBER also offers research job opportunities in the form of research fellowships and staff positions.
Regulatory Science Research Publications
Biologics Research Projects
General Biologics Research Allergenics Research Blood Research Cellular & Gene Therapy Research Tissue Research Vaccines Research Bacterial Polysaccharides, Enteric & Sexually Transmitted Diseases, Mycobacterial Diseases & Cellular Immunology, Respiratory & Special Pathogens, DNA Viruses, Hepatitis Viruses, Methods Development, Pediatric & Respiratory Viral Diseases, Retrovirus... Xenotransplantation Research
Asthma: The Hygiene Hypothesis[ARCHIVED]
Science & Research
FDA-wide Science and Research Information
Critical Path Initiative Jobs at the Center for Biologics Evaluation and Research (CBER) MCMi Intramural Research Projects Examples of regulatory science research conducted by FDA scientists through competitive grants from the Medical Countermeasures Initiative (MCMi)